1: Kociper B, Škorja Milić N, Ogrizek I, Miš K, Pirkmajer S. Inhibition of the ubiquitin-proteasome system reduces the abundance of pyruvate dehydrogenase kinase 1 in cultured myotubes. J Muscle Res Cell Motil. 2024 Sep;45(3):155-169. doi: 10.1007/s10974-024-09679-3. Epub 2024 Jul 31. 2: Yuan X, Zhang X, Wang H, Mao X, Sun Y, Tan L, Song C, Qiu X, Ding C, Liao Y. The Ubiquitin-Proteasome System Facilitates Membrane Fusion and Uncoating during Coronavirus Entry. Viruses. 2023 Sep 26;15(10):2001. doi: 10.3390/v15102001. 3: Yang L, Zhang Q, Yang Y, Wang Q. PYR-41, an inhibitor of ubiquitin-activating enzyme E1, attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice. FASEB J. 2023 Oct;37(10):e23210. doi: 10.1096/fj.202200951RRR. 24(13):10662. doi: 10.3390/ijms241310662.
合成参考文献
参考文献:10.1016/j.reprotox.2018.01.001 摘要:Yoshida K, Kang W, Nakamura A, Kawano N, Hanai M, Miyado M, Miyamoto Y, Iwai M, Hamatani T, Saito H, Miyado K, Umezawa A. Ubiquitin-activating enzyme E1 inhibitor PYR-41 retards sperm enlargement after fusion to the egg. Reprod Toxicol. 2018 Mar;76():71–7. doi: 10.1016/j.reprotox.2018.01.001. 参考文献:10.1007/s10555-017-9697-6 摘要:Mofers A, Pellegrini P, Linder S, D’Arcy P. Proteasome-associated deubiquitinases and cancer. Cancer and Metastasis Reviews. 2017 Nov 14;36(4):635–53. doi: 10.1007/s10555-017-9697-6.